Eric J. Ende - Insider Trading & Ownership

Entity
Individual
Location
C/O Matinas Biopharma Holdings, Inc., 1545 Route 206 South, Suite 302, Bedminster, NJ
Summary
The estimated net worth of Eric J. Ende is at least $1.82M dollars as of August 1, 2024. Eric J. Ende is the Director of AVADEL PHARMACEUTICALS PLC and owns shares of AVADEL PHARMACEUTICALS PLC (AVDL) stock worth about $1.82M.
All Insider Reports
All Insider Reports

Ownership of Eric J. Ende

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
AVDL AVADEL PHARMACEUTICALS PLC Director $1.82M Jul 30, 2024
MTNB Matinas BioPharma Holdings, Inc. Director Nov 1, 2023
NBSE NeuBase Therapeutics, Inc. Director Sep 9, 2022

Insider Transactions Reported by Eric J. Ende:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.